Pre-event smallpox vaccination for healthcare workers revisited--the need for a carefully screened multidisciplinary cadre.
As healthcare institutions are a focus of smallpox transmission early in an epidemic, several mathematical models support pre-event smallpox vaccination of healthcare workers (HCWs). The deciding factor for HCW voluntary vaccination is the risk of disease exposure versus the risk of vaccine adverse events. In a United States military population, with careful screening to exclude atopic dermatitis/eczema and immunosuppression, over 1 million vaccinia (smallpox) vaccinations were delivered with one fatality attributed to vaccination. Among 37901 United States civilian volunteer HCWs vaccinated, 100 serious adverse events were reported including 10 ischemic cardiac episodes and six myocardial infarctions - two were fatal. This older population had a higher rate of adverse events due to age-related coronary artery disease. T-cell mediated inflammatory processes induced by live vaccinia vaccination may have a role in the observed acute coronary artery events. With exclusion of individuals at risk for coronary artery disease, atopic dermatitis/eczema, and immunosuppression, HCWs can be smallpox vaccinated with minimal risk. A carefully screened multidisciplinary cadre (physician, nurse, infection control practitioner, technician), pre-event vaccinated for smallpox, will supply the necessary leadership to alleviate fear and uncertainty while limiting spread and initial mortality of smallpox.
Malone
John D
JD
Center for Biological Monitoring and Modeling, Pacific Northwest National Laboratory, MSIN:P7-51, 902 Battelle Boulevard, PO Box 999, Richland, WA 99352, USA. jdmalone@usuhs.mil
D004196:Disease Outbreaks / Q000517:prevention & control*; D006282:Health Personnel; D006801:Humans; D017757:Infectious Disease Transmission, Professional-to-Patient / Q000517:prevention & control*; D018570:Risk Assessment; D012899:Smallpox / Q000453:epidemiology / Q000517:prevention & control* / Q000635:transmission; D012900:Smallpox Vaccine / Q000009:adverse effects*; D014481:United States; D014611:Vaccination / Q000592:standards*; D014615:Vaccinia / Q000276:immunology
D012900:Smallpox Vaccine